Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioCorRx (BICX) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for BioCorRx (BICX) over the last 17 years, with Q3 2025 value amounting to -$586370.0.

  • BioCorRx's Other Operating Expenses rose 6057.72% to -$586370.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.6 million, marking a year-over-year increase of 3461.14%. This contributed to the annual value of $2846.0 for FY2024, which is 9665.75% down from last year.
  • According to the latest figures from Q3 2025, BioCorRx's Other Operating Expenses is -$586370.0, which was up 6057.72% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Other Operating Expenses registered a high of $154586.0 during Q3 2021, and its lowest value of -$1.5 million during Q3 2024.
  • Moreover, its 5-year median value for Other Operating Expenses was $2727.0 (2021), whereas its average is -$337502.8.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 301207.65% in 2023, then crashed by 3571750.48% in 2024.
  • Over the past 5 years, BioCorRx's Other Operating Expenses (Quarter) stood at $2727.0 in 2021, then skyrocketed by 228.97% to $8971.0 in 2022, then skyrocketed by 48.79% to $13348.0 in 2023, then crashed by 97.78% to $296.0 in 2024, then plummeted by 198197.97% to -$586370.0 in 2025.
  • Its last three reported values are -$586370.0 in Q3 2025, -$1.2 million for Q2 2025, and -$875817.0 during Q1 2025.